Skip to main content
Top
Published in: Clinical and Translational Oncology 10/2006

01-10-2006 | Brief Research Articles

Feasibilty study of gemcitabine and cisplatin administered every two weeks in patients with advanced urothelial tumors and impaired renal function

Authors: Joan Carles, Cristina Suárez, Carlos Mesía, Miquel Nogué, Albert Font, Montserrat Doménech, Marta Suárez, Ignasi Tusquets, M. Gallén, Joan Albanell, Xavier Fabregat

Published in: Clinical and Translational Oncology | Issue 10/2006

Login to get access
Metadata
Title
Feasibilty study of gemcitabine and cisplatin administered every two weeks in patients with advanced urothelial tumors and impaired renal function
Authors
Joan Carles
Cristina Suárez
Carlos Mesía
Miquel Nogué
Albert Font
Montserrat Doménech
Marta Suárez
Ignasi Tusquets
M. Gallén
Joan Albanell
Xavier Fabregat
Publication date
01-10-2006
Publisher
Springer-Verlag
Published in
Clinical and Translational Oncology / Issue 10/2006
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-006-0123-8

Other articles of this Issue 10/2006

Clinical and Translational Oncology 10/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine